Sinopharm unit, CanSinoBIO apply in China for COVID-19 vaccines’ public use approval

A unit of China National Pharmaceutical Group (Sinopharm) and CanSino Biologics Inc (CanSinoBIO) have applied for public use of their COVID-19 vaccines in China, which if granted would mean China has …